Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Amyris Inc AMRSQ

Chemicals Specialty Chemicals
Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F... see more

Recent & Breaking News (GREY:AMRSQ)

AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS

PR Newswire March 1, 2022

AMYRIS TO PRESENT AT THE 42nd ANNUAL COWEN HEALTH CARE CONFERENCE

PR Newswire February 28, 2022

AMYRIS TO HOST FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS CONFERENCE CALL ON MARCH 1

PR Newswire February 22, 2022

AMYRIS CLOSES ECOFABULOUS TRANSACTION, AND COMMENCES PRODUCTION OF CONSUMER PRODUCTS IN RENO, NEVADA PLANT

PR Newswire February 9, 2022

AMYRIS ANNOUNCES APPOINTMENT OF ANA DUTRA TO BOARD OF DIRECTORS

PR Newswire January 27, 2022

AMYRIS TO ACQUIRE MENOLABS FOR MENOPAUSE WELLNESS ACCELERATING GROWTH OF CONSUMER BUSINESS

PR Newswire January 24, 2022

AMYRIS TO PRESENT AT THE 40th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

PR Newswire January 5, 2022

AMYRIS AND IMMUNITYBIO COMPLETE JOINT VENTURE FOR NEXT GENERATION COVID-19 RNA VACCINE

PR Newswire January 3, 2022

AMYRIS AND MINERVA FOODS COMPLETE JOINT VENTURE AND LICENSE AGREEMENTS TO SCALE LOW CARBON PROTEIN PRODUCTION PLATFORM

PR Newswire December 23, 2021

Federman & Sherwood Announces Certification of Securities Class Action Lawsuit Against Amyris, Inc.

Business Wire December 10, 2021

Amyris Consumer Brands Deliver Record Black Friday Week

PR Newswire November 30, 2021

Amyris To Present At The Evercore ISI 4th Annual HealthCONx Conference On December 1, 2021

PR Newswire November 23, 2021

Amyris To Host Call Regarding Recent Financing Activity

PR Newswire November 18, 2021

Amyris Closes Upsized Offering Of $690.0 Million Of 1.50% Convertible Senior Notes Due 2026

PR Newswire November 15, 2021

Amyris Prices $600.0 Million Of 1.50% Convertible Senior Notes Due 2026

PR Newswire November 10, 2021

Amyris To Offer $400.0 Million Of Convertible Senior Notes Due 2026

PR Newswire November 8, 2021

Amyris, Inc. Reports Third Quarter 2021 Financial Results

PR Newswire November 8, 2021

Amyris Announces JV Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine

PR Newswire November 8, 2021

Amyris to Host Third Quarter 2021 Financial Results Conference Call on November 8

PR Newswire October 28, 2021

Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx(TM) Genome Engineering Platform

PR Newswire October 5, 2021